Veolia expands clinical and medical waste management services
Expanded capabilities will modernize traditional clinical waste hierarchy positions and can lower the stat emissions by virtually 70% compared to existing services
Veolia says it has expanded its medical waste management capabilities with the aim of addressing key issues for the healthcare sector and the NHS. The services will help organisations to make remoter progress on their net-zero ambitions through compliant optimised handling, management and treatment of waste streams that fall under the orange, yellow, red, undecorous and purple clinical waste categories.
Designed to treat infectious, anatomical, sharps , medicines waste and cytotoxic and cytostatic waste the expanded service will complement the existing offensive waste capabilities and unhook 15,000 tonnes of clinical waste topics per year to the market through a well-constructed self delivered service from hodgepodge to disposal. Backing the service are new defended clinical waste transfer facilities that can segregate HTI and Non-HTI waste streams so that they can be processed through specially well-timed and modified Energy Recovery Facilities, the company’s existing clinical capacity, and High Temperature Incinerator site at Ellesmere Port.
By using the processes ripened during the pandemic the service will modernize traditional clinical waste hierarchy positions, and can lower the stat emissions by virtually 70% (from 212.60kg/CO2e/tonne to 58.03kg/CO2e/tonne) compared to existing services . It moreover enables the ERF to generate up to 600 kWh electricity per tonne, and allows ferrous metal to be recovered for recycling.
This moves all Alternative Technology (AT) waste up the hierarchy from a D9 disposal lawmaking solution, with an environmental impact score of 12 delivered through autoclaving, to a R1 recovery lawmaking with an environmental impact score of 6 for thermal treatment with energy recovery. Removing the need for pre-sterilisation through autoclave services, it avoids both the stat produced from this energy intensive step, and eliminates the production of autoclave floc which requires remoter transport and spare stat impact.
Donald Macphail, Chief Operating Officer – Treatment at Veolia said: “Our expanded service offering is truly innovative in this market and completely changes the way clinical waste has been managed for many years. It demonstrates the transferral Veolia has made towards bringing new solutions that unhook waste hierarchy improvements and stat reduction solutions to our customers.
“By using the clinical waste for electricity and heat generation, and putting energy when into the National Grid, the healthcare sector will be playing an zippy role in helping UK energy security, and dependency on fossil fuels .”
Managing clinical wastes since 1996, Veolia will self-deliver the logistics element of the expanded service using the fleet, ranging from small vans to double deck articulated vehicles, which conform to the standards required for the compliant hodgepodge of UN3291 Clinical Waste and Hazardous Waste material, together with thus trained drivers.